Signals

← Signals

☆FBLG

20 in-universe funds with a nonzero position in FBLG within the trailing 4 quarters, as of 2026Q2

Catalyst Timeline merged from Insider (Form 4), 8-K and Ownership/dilution filings already on file -- not a live news feed Full insider history

DateTypeWhat happened
2026-09-18 8-K Item(s) 5.07, 7.01, 9.01
2026-09-16 Ownership Dilution filing by FibroBiologics, Inc. (D)
2026-09-15 8-K Item(s) 1.01, 3.02, 9.01
2026-08-24 8-K Item(s) 5.02, 7.01, 9.01
2026-07-24 8-K Item(s) 3.01 -- negative
2026-07-10 Ownership Dilution filing by FibroBiologics, Inc. (S-3)
2026-07-09 8-K Item(s) 5.02, 7.01, 9.01
2026-06-29 8-K Item(s) 1.01, 3.02, 7.01, 9.01
2026-06-29 Ownership Dilution filing by FibroBiologics, Inc. (D)
2026-06-23 8-K Item(s) 5.02, 5.07, 9.01
2026-05-06 8-K Item(s) 1.01, 9.01
2026-05-06 Ownership Dilution filing by FibroBiologics, Inc. (424B5)
2026-05-05 8-K Item(s) 5.02
2026-05-01 8-K Item(s) 1.01, 9.01
2026-05-01 Ownership Dilution filing by FibroBiologics, Inc. (424B5)
2025-12-16 Ownership Dilution filing by FibroBiologics, Inc. (D)
2025-12-15 Ownership Dilution filing by FibroBiologics, Inc. (424B5)
2025-12-03 Ownership Dilution filing by FibroBiologics, Inc. (D)
2025-12-03 Ownership Dilution filing by FibroBiologics, Inc. (D)
2025-11-25 Ownership Dilution filing by FibroBiologics, Inc. (424B5)

Flow ranking

Rank#17406
Score / z0.000 / -0.02
Consensus8.27 over 12 funds
Momentumnot computed

Price & positioning

130 cached closes, trailing year
Drawdownnot computed
Short interestnot computed

Forensics

No XBRL fundamentals on file for this issuer — either not backfilled yet, or a financial/REIT excluded from these ratios. Not the same as clean.

Insider

No Form 4 activity on file for this ticker.

8-K events

Negative / total1 / 7
FiledFormItems
2026-09-18 8-K 5.07, 7.01, 9.01
2026-09-15 8-K 1.01, 3.02, 9.01
2026-08-24 8-K 5.02, 7.01, 9.01
2026-07-24 8-K 3.01
2026-07-09 8-K 5.02, 7.01, 9.01
2026-06-29 8-K 1.01, 3.02, 7.01, 9.01
2026-06-23 8-K 5.02, 5.07, 9.01
2026-05-06 8-K 1.01, 9.01
2026-05-05 8-K 5.02
2026-05-01 8-K 1.01, 9.01
Showing the 10 most recent.

Ownership

13D / 13G / dilution0 / 0 / 5
FiledFormFiler
2026-09-16 D FibroBiologics, Inc.
2026-07-10 S-3 FibroBiologics, Inc.
2026-06-29 D FibroBiologics, Inc.
2026-05-06 424B5 FibroBiologics, Inc.
2026-05-01 424B5 FibroBiologics, Inc.
2025-12-16 D FibroBiologics, Inc.
2025-12-15 424B5 FibroBiologics, Inc.
2025-12-03 D FibroBiologics, Inc.
2025-12-03 D FibroBiologics, Inc.
2025-11-25 424B5 FibroBiologics, Inc.
Showing the 10 most recent.

LLM reads

Ticker Eval hasn't reached this ticker yet. It's gated to the top of the ranking, so this is an ordering artefact, not a judgement.
Quarter
Fund AUM ($M)
–
Fund Positions
–
Quarters Held
–

Fund holders

Fund ▾ Quality Q ▾ Positions ▾ Value ($M) ▾ % of Fund AUM ▾ Qtrs Held ▾ Δ 1Q ▾ Δ 2Q ▾ Δ 3Q ▾ Δ 4Q ▾
☆Cascade Financial Partners, LLC CIK 0002021208 0.667 279 0.1 0.0% 2 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Fund Evaluation Group, LLC CIK 0001356249 0.924 80 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆GEODE CAPITAL MANAGEMENT, LLC CIK 0001214717 0.990 4447 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆VANGUARD CAPITAL MANAGEMENT LLC CIK 0002100119 0.000 4092 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Qube Research & Technologies Ltd CIK 0001729829 0.210 2619 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆BlackRock, Inc. (BLK) CIK 0002012383 0.995 5652 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆BARCLAYS PLC (BCS, BCLYF) CIK 0000312069 0.956 4648 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆VANGUARD FIDUCIARY TRUST CO CIK 0000933478 0.000 4076 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Tower Research Capital LLC (TRC) CIK 0001533421 0.051 5180 0.0 0.0% 2 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆OSAIC HOLDINGS, INC. CIK 0001677044 0.882 7705 0.0 0.0% 2 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆UBS Group AG (UBS) CIK 0001610520 0.954 9044 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆ROYAL BANK OF CANADA (RY, RYLBF) CIK 0001000275 0.970 7109 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆ISLAY CAPITAL MANAGEMENT, LLC CIK 0001738560 0.215 230 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Grove Bank & Trust CIK 0001662212 0.546 886 0.0 0.0% 1 +0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆BNP PARIBAS FINANCIAL MARKETS CIK 0001166588 0.856 5105 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Allworth Financial LP CIK 0001555170 0.907 5124 0.0 0.0% 2 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆RENAISSANCE TECHNOLOGIES LLC CIK 0001037389 0.399 3140 0.0 0.0% 0 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆WELLS FARGO & COMPANY/MN (WFC, WFCNP, WFC-PA, WFC-PC, WFC-PD, WFC-PL, WFC-PY, WFC-PZ) CIK 0000072971 0.967 6822 0.0 0.0% 0 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Western Wealth Management, LLC CIK 0001767902 0.459 1001 0.0 0.0% 0 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
☆Vanguard Global Advisers, LLC CIK 0001811242 0.000 3638 0.0 0.0% 0 -0.0 pp +0.0 pp +0.0 pp +0.0 pp
Value and % of AUM are this fund's own disclosed long-equity book (13F does not report true firm AUM). Positions is the fund's total position count (all tickers, not just FBLG). Qtrs Held counts distinct quarters this fund has actually held FBLG (weight > 0), across every period we've rescored. Fund AUM and Positions filters apply to the fund's whole book, not its FBLG position size. Δ columns are the percentage-point change in FBLG's weight within each fund's book vs. the trailing 1/2/3/4 quarters (2026Q1 / 2025Q4 / 2025Q3 / 2025Q2) — a fund not yet holding it that far back is treated as 0%. Only in-universe (quality-scored) funds are shown, matching the Signals-tab methodology.
Long US-equity 13F disclosures only · up to 45-day reporting lag · sells = reduce/avoid, not short. JSON: /api/signals · /api/funds · /api/status